AMJ Financial Wealth Management Invests $215,000 in UnitedHealth Group Incorporated (NYSE:UNH)

AMJ Financial Wealth Management purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 425 shares of the healthcare conglomerate’s stock, valued at approximately $215,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Virtus ETF Advisers LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $718,000. Octavia Wealth Advisors LLC grew its holdings in UnitedHealth Group by 8.8% in the 2nd quarter. Octavia Wealth Advisors LLC now owns 740 shares of the healthcare conglomerate’s stock valued at $380,000 after buying an additional 60 shares during the last quarter. Arcus Capital Partners LLC grew its holdings in UnitedHealth Group by 40.1% in the 3rd quarter. Arcus Capital Partners LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,241,000 after buying an additional 703 shares during the last quarter. Great Valley Advisor Group Inc. grew its holdings in UnitedHealth Group by 41.8% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 26,614 shares of the healthcare conglomerate’s stock valued at $13,670,000 after buying an additional 7,851 shares during the last quarter. Finally, Crumly & Associates Inc. grew its holdings in UnitedHealth Group by 2.5% in the 2nd quarter. Crumly & Associates Inc. now owns 1,578 shares of the healthcare conglomerate’s stock valued at $810,000 after buying an additional 38 shares during the last quarter. 86.31% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.4 %

UNH stock opened at $489.75 on Wednesday. The company has a market cap of $457.60 billion, a P/E ratio of 23.20, a PEG ratio of 1.36 and a beta of 0.73. UnitedHealth Group Incorporated has a twelve month low of $445.73 and a twelve month high of $558.10. The company has a quick ratio of 0.82, a current ratio of 0.77 and a debt-to-equity ratio of 0.67. The business has a fifty day moving average of $518.45 and a 200-day moving average of $524.08.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating analysts’ consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion during the quarter, compared to the consensus estimate of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The firm’s revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.48 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 24.9 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th were paid a $1.65 dividend. The ex-dividend date was Friday, December 2nd. This represents a $6.60 dividend on an annualized basis and a yield of 1.35%. UnitedHealth Group’s payout ratio is 31.15%.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Loop Capital lifted their price objective on UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. SVB Leerink decreased their price objective on UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating on the stock in a report on Monday, October 17th. Morgan Stanley reissued an “overweight” rating and set a $587.00 price objective on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Credit Suisse Group boosted their price target on UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, December 7th. Finally, Royal Bank of Canada boosted their price target on UnitedHealth Group from $588.00 to $592.00 and gave the company an “outperform” rating in a research note on Monday, October 17th. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $599.39.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 450 shares of the business’s stock in a transaction dated Wednesday, December 7th. The stock was sold at an average price of $542.30, for a total value of $244,035.00. Following the completion of the transaction, the executive vice president now directly owns 8,736 shares of the company’s stock, valued at $4,737,532.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.